Related Experiment Videos
Chromosomal abnormalities in pleomorphic adenomas. Related to origin or karyotypic evolution?
Cancer Genetics and Cytogenetics
|June 1, 1991
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours.
British journal of cancer·2012
Chromosome analyses in dogs.
Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere·2012
Genetic characterization of dogs via chromosomal analysis and array-based comparative genomic hybridization (aCGH).
Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere·2012
Two new cases of polysomy 13 in canine prostate cancer.
Cytogenetic and genome research·2010
A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.
Cancer genetics and cytogenetics·2010
Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma.
Cancer genetics and cytogenetics·2010
Screening for DNA copy number aberrations in mucinous adenocarcinoma arising from the minor salivary gland: two case reports.
Cancer genetics and cytogenetics·2010
Screening for common copy-number variants in cancer genes.
Cancer genetics and cytogenetics·2010
Trisomy 17 in congenital plexiform (multinodular) cellular schwannoma.
Cancer genetics and cytogenetics·2010
Chromosomal alterations in Malaysian patients with nasopharyngeal carcinoma analyzed by comparative genomic hybridization.
Cancer genetics and cytogenetics·2010
Development of cecal volvulus after redo pancreas transplantation.
Journal of surgical case reports·2026
Primary Diffuse Large B-Cell Lymphoma of the External Auditory Canal with Extensive Local Extension: A Case Report and Literature Review.
Iranian journal of otorhinolaryngology·2026
Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fcγ receptor (FcγR) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy.
Research and practice in thrombosis and haemostasis·2026